Announced Fri, 19 Jun · 15:44 IST
Promoters confirm no new share encumbrances during FY 2025-26
Ownership Changes View source PDF
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹469.95
prior close
₹466.65
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.5-0.5-0.2+0.2+2.9+2.4+1.0+1.7+1.3+3.6+2.5——
Up moveDown movePending
AI summary
All promoter entities of Dr. Agarwal's Health Care, including family members, family trusts, and Dr. Agarwal's Eye Institute, have filed SEBI Regulation 31(4) declarations. Each promoter states they have not created any new encumbrance (pledge or charge) on their shares other than what was already disclosed during FY 2025-26. This is a routine annual compliance filing, not a new transaction.
Likely market impact
Routine compliance filing. No new pledges or encumbrances by promoters. Neutral for shareholders.